Musole Chipoya

Datos Biográficos

ID7804729
NOMBREMusole Chipoya
NOMBRESMusole
APELLIDOChipoya
FIRMACHIPOYA M
AFILIACIONESZambia National Public Health Institute
ORCID0000-0001-5103-9042
VERIFICADONo
TOTAL DE OBRAS3
TOTAL DE CITAS0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2023
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Factors associated with measles vaccine immunogenicity in children at University Teaching Hospitals, Lusaka, Zambia

    Open AccessPriscilla Nkonde Gardner, Jimmy Hangoma et al.ARTICLEPLOS Global Public Health2025

    Measles poses a significant global public health challenge, particularly in low-resource settings where vaccination coverage is limited. This study examined factors associated with measles vaccine immunogenicity in children aged 2–15 years at the University Teaching Children’s Hospital and the HIV Pediatric Centre of Excellence in Lusaka, Zambia. This comparative analytical cross-sectional study was conducted from April to July 2024, enrolling 20…

  • Evaluating the impact of Covid-19 on routine childhood immunizations coverage in Zambia

    Open AccessKelvin Mwangilwa, Charles Chileshe et al.ARTICLEPLOS Global Public Health2024

    There are growing concerns about the comeback of vaccine-preventable diseases. Epidemics exert shocks which affect other health performance indicators such as routine immunizations. Early model forecasts indicate decreased use of immunization services, which puts children at greater risk. Concerns about an increase in morbidity and mortality for illnesses other than COVID-19, particularly in children missing routine vaccinations, are of public he…

  • Evaluation of the Acute flaccid paralysis surveillance indicators in Zambia from 2015–2021

    Open AccessBarnabas Bessing, Edward Dagoe et al.ARTICLEBMC Public Health2023

    The AFP surveillance system in Zambia is doing well. However, additional efforts are needed to improve early detection of cases; stool sample collection, transportation and monitoring to ensure arrival in good condition in the laboratory; and improve 60-days follow-up evaluation for evidenced-based classification of inadequate AFP cases and proper care